Objectives: To identify factors that impact the visibility of the endometrial echo (EE) on transvaginal sonography (TVS) of postmenopausal women. Methods: A prospective study of women, 50 years and older, who underwent TVS. EE was measured according to IETA guidelines. An EE visibility scoring system was developed (0-not seen, 1-poorly seen, 2-borderline, 3-satisfactory and 4-optimal visibility). Images were scored by three solonogists trained in the EE scoring system. Patient and sonographic characteristics were compared between those with low visibility scores (0-2) and those with adequate visibility scores (3-4). P<0.05 was considered significant. Results: 440 scans were evaluated. Mean patients age was 60.1y 
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Objectives: Postmenopausal bleeding (PMB) is a relatively common presentation and the incidence of endometrial malignancy is rising. Investigations should therefore be cost-efficient and clinically effective for the population at risk. This study aimed to identify the clinical effectiveness of current PMB investigations. Methods: Embase search of English literature on PMB investigations published during 1990-2016. Results: Transvaginal ultrasound scan is currently the first line investigation of choice as it has been shown to be effective in determining the need for more invasive investigations based on endometrial thickness (ET), but evaluating the risk of malignancy based on assessment of ET alone has poor specificity. Endometrial polyps are a possible risk for focal endometrial pathology and malignancy in symptomatic patients, and there is also evidence that a thin endometrium does not rule out endometrial cancer.
Invasive investigations such as hysteroscopy have both risks for patients and major cost and resource implications. 2d transvaginal scan on its own is limited in identifying endometrial pathology. In some studies, the accuracy of saline infusion sonohysterography (SIS) is reported to have reached that of hysteroscopy. Hysteroscopy is an expensive and painful investigation that is not risk-free, nor does it eliminate the need for a biopsy which is still necessary to confirm pathology. The sensitivity and specificity of Pipelle ® endometrial biopsy are reported to be 97% and 99.6% respectively; SIS with hysteroscopy detected focal endometrial (pre)malignancy in 6% of women who had benign endometrial sampling in one study.
Conclusions:
We need evidence from descriptive studies after a postmenopausal scanning accreditation program. Only then would we be able to improve from current practice. Evidence should focus on ageing population related risks, and cost-effective pathways for investigations of PMB given early detection of endometrial adenocarcinoma and atypical hyperplasia prevents radiotherapy. All these cases have been characterised as neoplastic in the initial report based on IETA rules (100%). No statistically significant difference has been observed regarding the 3D parameters produced between benign and malignant lesions. It was proven that these parameters failed to predict malignancy in 44 % of the recruited patients. Conclusions: Despite the limited number of data, it is clearly shown the superiority regarding subjective impression of examiner based on IETA rules and definitions as compared to 3D ultrasonic analysis via Render Mode. Further prospective studies must be organised in order gynecologists to become familiar to specific suggestions of IETA model.
